Uploaded on Nov 28, 2023
The ocular drug delivery market trends include increase in prevalence of eye diseases, strong product pipeline, and surge in product approvals. The rise in prevalence of eye disorders is a major driving factor in the growth of the ocular drug delivery market.
Ocular Drug Delivery Market
OCULAR DRUG
DELIVERY MARKET
By Technology (Topical, Ocular Insert, Intraocular Implants, In-Situ Gel, Others), By Formulation
Type (Solution, Emulsion, Suspension, Ointment, Others), By Disease Indication (Glaucoma, Diabetic
Retinopathy, Dry Eye Syndrome, Age related macular degeneration, Others), By End User (Hospitals,
Ophthalmic Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032
P R I M E D E T E R M I N A N T S O F G R O W
T H • Request Free Download Sample:
https://www.alliedmarketresearc
h.com/request-sample/3646
• Ocular drug delivery is the process
of delivering drugs to the eyes in
order to treat different types of eye
disorders such as diabetic
retinopathy, dry eye syndrome, age-
related macular degeneration, and
others. This specialized delivery
system aims to minimize systemic
side effects while optimizing the
therapeutic effects of medications
by addressing the limitations of the
ocular environment. Ocular drug
delivery systems are designed to
improve the drug delivery and
effectively provide medications to
the intended tissues inside the eye.
Ocular drug delivery involves the
use of a variety of techniques, such
as implants, ointments, eye drops,
injections, and contact lenses.
RECENT DEVE
LOPMENTS IN
OCULAR DRUG Contact Lens Drug Delivery:
Integration of drug delivery systems
DELIVERY into contact lenses for controlled and sustained release of drugs, providing a
MARKET non-invasive and patient-friendly approach.
Intravitreal Injections: Ongoing
developments in intravitreal injection
technologies, with a focus on
minimizing discomfort, reducing
injection frequency, and improving
drug distribution within the eye.
KEY
PLAYERS:
Santen
Nocox Pharmace Novaliq utical Co., GmbH
Ltd.
Bausch
Health Alimera Clearside
Companies Sciences, Biomedical
, Inc. Inc. , Inc.
Kiora
AbbVie Pharmace Ocular
Inc. uticals, Therapeuti
Inc. x, Inc.
EyePoint
Pharmace
uticals,
Inc.
BY
REGION:
• North America (U.S., Canada, Mexico)
• Europe (France, Germany, Italy, Spain, UK,
Rest of Europe)
• Asia-Pacific (China, Japan,
India, South Korea, Australia, Rest of Asia-
Pacific)
• LAMEA (Brazil, South Africa, Saudi Arabia,
Rest of LAMEA)
CONTACT
US:
• David Correa
• 5933 NE Win Sivers Drive
• #205, Portland, OR 97220
• United States
• Toll-Free: 1-800-792-5285
• UK: +44-845-528-1300
• Hong Kong: +852-301-84916
• India (Pune): +91-20-66346060
• Fax: +1-855-550-5975
• [email protected]
• Web: https://www.alliedmarketresearch.com
• Follow Us on: LinkedIn Twitter
THANK YOU !
Comments